Clinical Trials Logo

Psychotic Disorders clinical trials

View clinical trials related to Psychotic Disorders.

Filter by:

NCT ID: NCT04512066 Completed - Clinical trials for Schizophrenia, Schizoaffective Disorder

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Start date: September 8, 2020
Phase: Phase 2
Study type: Interventional

This study will investigate the efficacy and safety of RO6889450 as monotherapy in participants experiencing an acute exacerbation of symptoms of schizophrenia or schizoaffective disorder.

NCT ID: NCT04509778 Completed - Clinical High-risk Clinical Trials

Develop a Psychosis Risk Calculator for Chinese Mental Health Servises

Start date: December 1, 2016
Phase:
Study type: Observational

This project will use the collected clinical and biological information of high-risk groups, use embedded computer chips, and use big data background analysis system to comprehensively evaluate the risk of high-risk groups, and build a mental illness risk estimator completely relying on the sample data of Chinese population and with independent intellectual property rights. The calculator function and the risk calculation standard verified by the model can obtain the risk degree of each patient's progress to psychosis in the next two years. This calculator will play an important role in the prevention and treatment of psychosis.

NCT ID: NCT04457635 Completed - Mental Disorder Clinical Trials

Effect of a 'Rapid-Return-to-work Program' in Mild Mental Disorders.

Start date: September 2013
Phase: N/A
Study type: Interventional

This study is a pragmatic randomized controlled trial (RCT) evaluating the effect of brief versus short psychotherapy in subjects with substantial mental complaints.

NCT ID: NCT04444180 Completed - Clinical trials for Clinical High Risk for Psychosis

The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis

Start date: July 6, 2019
Phase:
Study type: Observational [Patient Registry]

Schizophrenia is one of the most consumptive diseases, which brings great loss to patients and their families, and even to the society. Clinical High Risk for Psychosis (CHR) is a concept put forward on the basis of the prodromal stage of schizophrenia. Over the past 20 years, the identification and intervention of CHR has become the focus of psychiatric research, with the primary goal of early identification of biomarkers of susceptibility to schizophrenia and the development of individualized interventions to prevent or delay progression. Longitudinal studies have shown that CHR converted to schizophrenia mainly within two years, with a risk of about 30 percent. Self-disorder is one of the core characteristics of schizophrenia. The two most basic experiences of self-representation are sense of ownership and sense of agency. Sense of ownership refers to the sense that "I" perceives "my" body, while sense of agency refers to the sense that "I" experiences "my" actions and their consequences are initiated by "me". Some studies have shown that patients with schizophrenia show defects in the sense of ownership and agency. The most commonly used paradigm for observing "sense of ownership" and "sense of agency" is the rubber hand illusion (RHI) or the virtual hand illusion (VHI). In this study, the VHI experimental paradigm will be used to detect the self-representation of the individuals at high risk for psychosis, and the clinical outcome will be observed for one year.The hypothesis is that the subjects who exhibit abnormal illusion experience in VHI experiment are more likely to transition into psychotic disorders.

NCT ID: NCT04432129 Completed - Depression Clinical Trials

Integrated Mental Health Care and Vocational Rehabilitation to People With to Common Mental Disorders

IBBIS II
Start date: June 9, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of an integrated mental health care and vocational rehabilitation intervention for people on sick leave because of depression, stress, anxiety, personality- and functional disorders in Denmark

NCT ID: NCT04429412 Completed - Clinical trials for Brief Psychotic Disorder

Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

The main aim of the study is to evaluate the effectiveness of Individualized Meta-Cognitive Training (EMC +), in people with psychosis of brief evolution on symptoms, especially on positive symptoms. Secondary aims would be to assess the effect of EMC+ in metacognition, psychosocial and neuropsychological functioning, and to assess the maintenance of program effects on 6 months.

NCT ID: NCT04418570 Completed - Psychotic Disorders Clinical Trials

Hormonal and Inflammatory Biomarkers and Response to Cognitive Remediation in Recent-onset Psychosis

Start date: July 2016
Phase: N/A
Study type: Interventional

This study aims to explore whether hormones or inflammatory markers are associated with cognitive changes following cognitive remediation therapy (CRT) in people with a recent-onset psychotic disorder. The following biomarkers for treatment response will be considered: hormones related to the hypothalamic-pituitary-adrenal (HPA) axis (plasma cortisol, cortisol awakening response, diurnal cortisol slope, salivary cortisol at assessment), free thyroxine (F-T4), prolactin, or inflammatory markers. This study was designed as a pilot clinical trial in order to know the feasibility of the intervention and to calculate the effect sizes of different hormonal and inflammatory variables on cognition. This approach would allow the design of future larger clinical trials to test specific hypotheses generated with this study.

NCT ID: NCT04418011 Completed - Schizophrenia Clinical Trials

Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders

ModSoCCS
Start date: November 30, 2020
Phase: N/A
Study type: Interventional

In this study, the investigators will be examining the effects of repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) on social cognitive impairments in individuals with schizophrenia spectrum disorders. Participants will be chosen by chance to receive either active rTMS stimulation, active iTBS stimulation, sham rTMS, or sham iTBS. The investigators predict that active 10Hz and iTBS stimulation will improve social cognitive impairments compared to sham stimulation. We aim to identify which type of active stimulation is most effective at inducing changes social cognition brain circuitry and secondarily which type of active stimulation is best tolerated and most effective at inducing changes in social cognitive performance.

NCT ID: NCT04379349 Completed - Psychotic Disorders Clinical Trials

Using Short Message Service as a Means of Clinical Engagement in Early Psychosis

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Engagement with clinical services for youth with early psychosis represents a significant challenge, with up to 40% of patients dropping out of treatment in the first year. This has been linked to worse illness outcomes and represents a significant barrier to recovery for these patients. This study aims to evaluate the efficacy of short message service (SMS) as a means of improving clinical engagement in early-episode psychosis populations by bridging contact between appointments with weekly check-ins/reminders. These weekly check-ins during the first year of treatment will serve as an additional opportunity to reach out to patients and give them a chance to do the same with their care teams, with patient responses triggering clinician follow-up if necessary.

NCT ID: NCT04373590 Completed - Early Psychosis Clinical Trials

Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis

Start date: February 27, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of an antipsychotic medication decision aid and interpersonal and cognitive factors, such as attachment style and motivation, on emerging adults' ability to engage in shared decision making regarding their medications.